Rapid electrokinetic isolation of cancer-related circulating cell-free DNA directly from blood

Clinical Chemistry

Volumn 60, Issue 3, 2014, Pages 500-509

  Sonnenberg, Avery ^a   Marciniak, Jennifer Y ^a   Rassenti, Laura ^b   Ghia, Emanuela M ^b   Skowronski, Elaine A ^c   Manouchehri, Sareh ^a   McCanna, James ^c   Widhopf II, George F ^b   Kipps, Thomas J ^b   Heller, Michael J ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULATING CELL FREE DNA; DNA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; DNA SEQUENCE; ELECTROKINETIC MICROARRAY DEVICE; ELUTED FOR QUANTIFICATION; FLUORESCENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN HEAVY CHAIN GENE; MEDICAL DEVICE; POLYMERASE CHAIN REACTION SYSTEM; RAPID ELECTROKINETIC ISOLATION;

DNA, NEOPLASM; ELECTROPHORESIS, AGAR GEL; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

EID: 84895819608     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.214874     Document Type: Article

References (40)

1. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011;11:426-37.
2. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer-a survey. Biochim Biophys Acta 2007;1775:181-232.
3. Ziegler A, Zangemeister-Wittke U, Stahel RA. Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev 2002;28:255-71. (Pubitemid 35439439)
4. Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003;21:3902- 8.
5. Sozzi G, Conte D, Mariani L, Lo Vullo S, Roz L, Lombardo C, et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 2001;61: 4675-8. (Pubitemid 32691874)
6. Gautschi O, Bigosch C, Huegli B, Jermann M, Marx A, Chasse E, et al. Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol 2004;22:4157- 64.
7. Forshew T, Murtaza M, Parkinson C, Gale D, Tsui DW, Kaper F, et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med 2012; 4:136ra68.
8. Gormally E, Caboux E, Vineis P, Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 2007;635:105-17. (Pubitemid 46756399)
9. Diehl F, Li M, Dressman D, He Y, Shen D, Szabo S, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A 2005;102:16368-73. (Pubitemid 41688920)
10. Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med 2008;14:985-90.
11. Swisher EM, Wollan M, Mahtani SM, Willner JB, Garcia R, Goff BA, et al. Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer. Am J Obstet Gynecol 2005;193:662-7. (Pubitemid 41261459)
12. Board RE, Wardley AM, Dixon JM, Armstrong AC, Howell S, Renshaw L, et al. Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer. Breast Cancer Res Treat 2010;120: 461-7.
13. Leary RJ, Sausen M, Kinde I, Papadopoulos N, Carpten JD, Craig D, et al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med 2012;4:162ra154.
14. Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 2004;351:893-901. (Pubitemid 39096916)
15. Ghia EM, Jain S, Widhopf GF, 2nd, Rassenti LZ, Keating MJ, Wierda WG, et al. Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection. Blood 2008;111:5101- 8.
16. Deligezer U, Erten N, Akisik EE, Dalay N. Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma. Exp Mol Pathol 2006;80:72- 6.
17. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998; 102:1515-25. (Pubitemid 28492218)
18. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848 -54.
19. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94: 1840-7. (Pubitemid 29430399)
20. Kipps TJ, Rassenti LZ, Duffy S, Johnson T, Kobayashi R, Carson DA. Immunoglobulin V gene expression in CD5 B-cell malignancies. Ann NY Acad Sci 1992;651:373- 83.
21. Guarini A, Gaidano G, Mauro FR, Capello D, Mancini F, De Propris MS, et al. Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood 2003;102:1035-41. (Pubitemid 36917801)
22. Giudicelli V, Chaume D, Jabado-Michaloud J, Lefranc MP. Immunogenetics sequence annotation: the strategy of IMGT based on IMGT-ONTOLOGY. Stud Health Technol Inform 2005;116:3-8.
23. Kabat EA, Wu TT. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites. J Immunol 1991; 147:1709-19.
24. Becker FF, Wang XB, Huang Y, Pethig R, Vykoukal J, Gascoyne PR. Separation of human breast cancer cells from blood by differential dielectric affinity. Proc Natl Acad Sci U S A 1995;92:860-4.
25. Asbury CL, van den Engh G. Trapping of DNA in nonuniform oscillating electric fields. Biophys J 1998;74:1024 -30.
26. Cheng J, Sheldon EL, Wu L, Heller MJ, O'Connell JP. Isolation of cultured cervical carcinoma cells mixed with peripheral blood cells on a bioelectronic chip. Anal Chem 1998;70:2321- 6.
27. Alazzam A, Stiharu I, Bhat R, Meguerditchian AN. Interdigitated comb-like electrodes for continuous separation of malignant cells from blood using dielectrophoresis. Electrophoresis 2011;32: 1327-36.
28. Morgan H, Hughes MP, Green NG. Separation of submicron bioparticles by dielectrophoresis. Biophys J 1999;77:516 -25.
29. Asbury CL, Diercks AH, van den Engh G. Trapping of DNA by dielectrophoresis. Electrophoresis 2002;23:2658-66. (Pubitemid 35023707)
30. Han KH, Frazier AB. Lateral-driven continuous dielectrophoretic microseparators for blood cells suspended in a highly conductive medium. Lab Chip 2008;8:1079-86. (Pubitemid 351904825)
31. Gao J, Sin ML, Liu T, Gau V, Liao JC, Wong PK. Hybrid electrokinetic manipulation in high-conductivity media. Lab Chip 2011;11:1770-5.
32. Pratt ED, Huang C, Hawkins BG, Gleghorn JP, Kirby BJ. Rare cell capture in microfluidic devices. Chem Eng Sci 2011;66:1508-22.
33. Krishnan R, Sullivan BD, Mifflin RL, Esener SC, Heller MJ. Alternating current electrokinetic separation and detection of DNA nanoparticles in high-conductance solutions. Electrophoresis 2008;29: 1765-74. (Pubitemid 351663874)
34. Krishnan R, Heller MJ. An AC electrokinetic method for enhanced detection of DNA nanoparticles. J Biophotonics 2009;2:253- 61.
35. Krishnan R, Dehlinger DA, Gemmen GJ, Mifflin RL, Esener SC, Heller MJ. Interaction of nanoparticles at the DEP microelectrode interface under high conductance conditions. Electrochem Commun 2009;11:1661-6.
36. Sonnenberg A, Marciniak JY, Krishnan R, Heller MJ. Dielectrophoretic isolation of DNA and nanoparticles from blood. Electrophoresis 2012;33: 2482-90.
37. Sonnenberg A, Marciniak JY, McCanna J, Krishnan R, Rassenti L, Kipps TJ, et al. Dielectrophoretic isolation and detection of cfc-DNA nanoparticulate biomarkers and virus from blood. Electrophoresis 2013;34:1076-84.
38. Widhopf GF, Rassenti LZ, Toy TL, Gribben JG, Wierda WG, Kipps TJ. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 2004; 104:2499-504.
39. van der Drift MA, Hol BE, Klaassen CH, Prinsen CF, van Aarssen YA, Donders R, et al. Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer. Lung Cancer 2010;68:283-7.
40. Guadalajara H, Dominguez-Berzosa C, Garcia- Arranz M, Herreros MD, Pascual I, Sanz-Baro R, et al. The concentration of deoxyribonucleic acid in plasma from 73 patients with colorectal cancer and apparent clinical correlations. Cancer Detect Prev 2008;32:39-44.